<DOC>
	<DOCNO>NCT00976443</DOCNO>
	<brief_summary>Obesity important public health problem United States . The investigator hypothesize stomach injection botulinum toxin A ( BTA ) , deliver endoscope use endoscopic ultrasound ( EUS ) , may cause delayed gastric emptying , satiation , reduction body weight . This protocol design study effect safety gastric BTA injection . Subjects randomize receive placebo one two different dos BTA inject stomach one endoscopy , perform via mouth . Gastric emptying , satiation , symptom , psychological dimension eat behavior , caloric intake record injection , subject see follow-up 24 week .</brief_summary>
	<brief_title>Effects Gastric Antral Botulinum Toxin Injections Obese Subjects</brief_title>
	<detailed_description>Additional information regard study intervention obtain contact study staff .</detailed_description>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age ≥ 18 year ≤ 60 year BMI ≥ 35 kg /m² No history diabetes , gastric small bowel surgery , know gastroparesis , prior peptic ulcer , esophagitis , gastrointestinal stricture . Not pregnant nursing . Women childbearing potential must negative urine pregnancy test within 48 hour prior gastric empty study , Botox injection procedure . Unable unwilling provide write informed consent ASA Class III high Chronic upper abdominal pain , nausea , vomit Allergy botulinum toxin Delayed gastric empty ( abnormal T ½ ) baseline scintigraphic gastric empty test Active esophageal , gastric , duodenal ulceration time diagnostic EGD Allergic penicillin AND quinolones Subject take warfarin ( Coumadin ) clopidogrel ( Plavix ) week precede EUS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Gastric Emptying</keyword>
	<keyword>Satiation</keyword>
	<keyword>Endosonography</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Feeding Behavior</keyword>
</DOC>